2017•Annals of OncologyOpen access

Multicenter phase 2 trial of varlitinib versus lapatinib in combination with capecitabine in patients with HER2+ metastatic breast cancer (MBC) who failed prior trastuzumab therapy

S.C. Lee, S-C. Chen, M-S Dai, G.E. Lee, CL Liu, Arlene Chan, H-K Chang, L-M Tseng, Wen Yee Chay, Louis WC Chow, J.L. Peneyra, K-M Rau, H-C Wang, Adonis A. Guancia, M Head, Joanne Chiu, Bridget A. Robinson, Bertil Lindmark, Nicola McIntyre, C.I Hsieh

Open full text 5 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Capecitabine, Lapatinib, Trastuzumab, Internal medicine, Metastatic breast cancer, Refractory (planetary science), Breast cancer